{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0014491/OMIM:616098","label":"Immunodeficiency 37","mondoId":"MONDO:0014491","onsetQualifier":null,"recordKeys":["0b44324c385d8fa7823e1bc1f6a74bb1a68253f4e3228ab3ba8c0555d51d371c","2a6077d8a9c2ccc7c3f23f68708f9da0a6d81ff17926645b6fd2b7cbdaf9631c","684524b6137bee4dac827ba2934048a949cebf28e529c86b128f36c75f8c024a","be4b85ed1aaaeca7a2cee7b8accdb6d0332defc1ee7c62868083a75f482b35cb","d2cb52d207758a60c615a56a9781b4848e6f7788d238cb2f4763ead83172de93","e7e1c7f6a12b9c87eb1a887dc4796249a3b80af752c59ea1f61ee52f714d68c1","eea7602c871b01d289f5d44ce17593da778d4a0cd9b6959443f10e91866f1a41","f6b19807d25905f00fd277d07112f61c739d55b757303aab0dfa2d1891c7d395"],"recordQualifiers":{},"scopeLabel":"OMIM:616098","sourceIds":["OMIM:616098"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0014491/OMIM:616098"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"omim":0,"orphanet":0,"published":8}},"features":[{"hpoId":"HP:0002583","label":"Colitis","primary":false},{"hpoId":"HP:0410388","label":"Decreased central memory CD4+ T cell proportion","primary":false},{"hpoId":"HP:0004313","label":"Decreased circulating immunoglobulin concentration","primary":false},{"hpoId":"HP:0002721","label":"Immunodeficiency","primary":false},{"hpoId":"HP:0002383","label":"Infectious encephalitis","primary":false},{"hpoId":"HP:0002719","label":"Recurrent infections","primary":false},{"hpoId":"HP:0001250","label":"Seizures","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0014491","records":[{"frequencyKind":"count","key":"0b44324c385d8fa7823e1bc1f6a74bb1a68253f4e3228ab3ba8c0555d51d371c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616098","disease_name":"Immunodeficiency 37","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:25365219","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"2a6077d8a9c2ccc7c3f23f68708f9da0a6d81ff17926645b6fd2b7cbdaf9631c","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:616098","disease_name":"Immunodeficiency 37","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002721","is_excluded":false,"label":"Immunodeficiency","onset_id":null,"reference":"PMID:25365219","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"684524b6137bee4dac827ba2934048a949cebf28e529c86b128f36c75f8c024a","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:616098","disease_name":"Immunodeficiency 37","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002583","is_excluded":false,"label":"Colitis","onset_id":null,"reference":"PMID:25365219","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"be4b85ed1aaaeca7a2cee7b8accdb6d0332defc1ee7c62868083a75f482b35cb","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:616098","disease_name":"Immunodeficiency 37","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0410388","is_excluded":false,"label":"Decreased central memory CD4+ T cell proportion","onset_id":null,"reference":"PMID:25365219","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d2cb52d207758a60c615a56a9781b4848e6f7788d238cb2f4763ead83172de93","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616098","disease_name":"Immunodeficiency 37","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002383","is_excluded":false,"label":"Infectious encephalitis","onset_id":null,"reference":"PMID:25365219","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e7e1c7f6a12b9c87eb1a887dc4796249a3b80af752c59ea1f61ee52f714d68c1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616098","disease_name":"Immunodeficiency 37","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"PMID:25365219","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"eea7602c871b01d289f5d44ce17593da778d4a0cd9b6959443f10e91866f1a41","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:616098","disease_name":"Immunodeficiency 37","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004313","is_excluded":false,"label":"Decreased circulating immunoglobulin concentration","onset_id":null,"reference":"PMID:25365219","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f6b19807d25905f00fd277d07112f61c739d55b757303aab0dfa2d1891c7d395","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:616098","disease_name":"Immunodeficiency 37","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002719","is_excluded":false,"label":"Recurrent infections","onset_id":null,"reference":"PMID:25365219","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"immunodeficiency-37","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"immunodeficiency 37"},"schemaVersion":1}